About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Back to clinical trial search

COMPLETEDPhase 4NCT01755026

Serum and Tissue Cefazolin Concentrations in Patients Undergoing Cesarean Delivery

Patients undergoing Cesarean delivery (C-Section) with a body mass index of 35 or greater (this BMI number is in the obese range) will be given either 2 grams or 4 grams of an antibiotic before surger...

Lead sponsor: Michael Stitely•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

Michael Stitely

Age

18 - No limit years

Sex

FEMALE

Healthy Volunteers

No

Inclusion Criteria

•1. Age 18 years or above
•2. Body mass index (BMI) of 35 or greater at the time of the first obstetric clinic visit
•3. Undergoing cesarean delivery

Exclusion Criteria

•1. BMI less than 35.
•2. Not undergoing Cesarean delivery.
•3. Age less than 18 years.
•4. Pre-existing infection.
•5. Allergy to cephalosporin medications or a history of an anaphylactic reaction to penicillin.
•6. Cesarean delivery being performed under emergent circumstances.

Related studies

Five PLus Year EffIcacy of Endoscopic Sleeve Gastroplasty (ESG) for Sustained WeigHT Loss

NCT06894498 · Obesity and Obesity-related Medical Conditions, Weight Loss

Intensive Glycemic Targets in Overweight and Obese Women With Gestational Diabetes

NCT05124808 · Gestational Diabetes, Pregnancy, High Risk, and more

RECRUITINGPhase 3

Mirikizumab Administered at the Same Time as Tirzepatide in Adult Participants With Moderately to Severely Active Ulcerative Colitis and Obesity or Overweight: Phase 3b Study

NCT06937086 · Ulcerative Colitis, Obesity or Overweight

RECRUITINGPhase 3

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

NCT07595549 · Obesity, Overweight and/or Obesity, and more

The Application of Infrared Thermography in the Prediction of Skin Healing in Surgery

NCT07524062 · Wound Healing, Surgical Wound Infection, and more

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: August 21, 2013Terms

Trial snapshot

StatusCOMPLETED

PhasePHASE4

Enrollment23

Start dateNov 2010

Last updatedAug 21, 2013

Condition

Cesarean Delivery Wound Infection Obesity

Locations shown

West Virginia University Hospital

Morgantown, West Virginia

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: August 21, 2013Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions